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Instructions for Authors 
 
ABOUT 
Molecular Imprinting (MI) is an international journal devoted to the rapid publication of papers 
especially focused on all aspects of molecular imprinting. It is a platform for researchers to share their 
new findings, developments and applications in all topics of molecular imprinting such as molecular 
imprinting mechanism, applications (separation, sensoring, catalysis, biomedical materials, etc), 
nanotechnology, new synthetic approaches and concepts, MIP characterization, etc. 
This journal publishes high standard original papers, covering all experimental and theoretical 
contributions to the challenging field of molecular imprinting. 
CRITERIA FOR PUBLICATION 
The primary criteria for judging the acceptability of a manuscript are: its originality, scientific 
importance and interest to a general biological audience. See our Editorial Policy for more details. 
PUBLICATION FORMATS 
Molecular Imprinting considers submissions of:  
 Research Article – The default format for reporting research results. There is no length restriction. 
 Review Article – Used to submit literature reviews on a topic of interest. The article should contain 
a broad, balanced and fair perspective of the topic, identifying trends and/or gaps in the literature 
or providing a new synthesis of existing literature. Reviews should be scientifically sound and 
should describe the most relevant and recent contributions. 
 Mini-Review Article – A shorter form of a Review Article intended for a brief analysis of a focused 
topic on advances in the field of molecular imprinting. It discusses recent experimental research, 
highlights recent developments in fast-moving areas and suggests areas that require additional 
research. 
 Communication – This format is intended for the presentation of brief observations that do not 
warrant full-length papers. An empirical report resulting from analysis of collected data to address 
one or more research questions and/or hypotheses. 
 Rapid Communication – This format should be used to report on recent high quality research 
results of special importance and novelty, which merit urgent publication (6-7 weeks). It may be 
followed by a regular article developing the ideas introduced in the Rapid Communication. The 
length should not exceed 4-5 pages. Authors are asked to provide an explanation why their 
contribution should be handled via this rapid channel. The decision to publish will strictly depend 
on enthusiastic recommendations by the reviewers. 
 Vision Paper – This format is a forum for presentation of scientific discussion providing novel 
insight into significant questions in molecular imprinting. It identifies and predicts trends and 
directions for future research – provides a “vision of the future”. Vision papers are evaluated based 
on having a clear specification of possible research opportunities that come directly from present 
state-of-the-art subject domain knowledge. 
 Letter to the Editor – A brief discussion of an article published in Molecular Imprinting. Especially if 
the conclusions are contrary to the original ones. The length should be comparable to that of a 
Rapid Communication. 
 Erratum – A very short form used to correct a substantial error/misprint found by the author in the 
previously published paper. 
ELECTRONIC SUBMISSION 
All submissions must be made electronically via the Editorial Manager - an online submission and peer 
review system. First-time users must create an Author account to obtain a user ID and password 
required to enter the system. All manuscripts receive individual identification codes that should be 
used in any correspondence with regard to the publication process. If you experience difficulties with 
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the manuscript submission website, please contact the Editorial Office at 
molim.editorial@degruyteropen.com.   
Manuscripts submitted under multiple authorship are reviewed on the assumption that all listed 
authors concur in the submission and are responsible for its content; they must have agreed to its 
publication and have given the corresponding author the authority to act on their behalf in all matters 
pertaining to publication. The corresponding author is responsible for informing the coauthors of the 
manuscript status throughout the submission, review, and production process. 
ELECTRONIC FORMATS ALLOWED 
We accept submission of text, tables and figures as separate files or as a composite file. For your 
initial submission, we recommend you upload your entire manuscript, including tables and figures, as 
a single PDF file. If you are invited to submit a revised manuscript, please provide us with individual 
files: an editable text and publication-quality figures. 
Text files can be submitted in the following formats: MS Word - standard DOCUMENT (.DOC) or RICH 
TEXT FORMAT (.RTF); PDF (not applicable for re-submitted or accepted manuscripts, see below). 
Tables should be submitted as MS Word or PDF (not applicable for re-submitted or accepted 
manuscripts, see below). Please note that a straight Excel file is not an acceptable format. 
Graphics files can be submitted in any of the following graphic formats: EPS; BMP; JPG; TIFF; GIF or 
PDF. Please note that Powerpoint files are not accepted. 
Any articles that have been prepared in LaTeX will be accepted for review, but only in PDF format. 
Post-acceptance, text files of the revised manuscript and tables are required for use in the production. 
Authors should clearly indicate the location(s) of tables and figures in the text if these elements are 
given separately or at the end of the manuscript. If this information is not provided to the editorial 
office, we will assume that they should be left at the end of the text. 
FIRST-TIME SUBMISSION OF MANUSCRIPTS 
It is important that authors include a cover letter with their manuscript. Please explain why you 
consider your manuscript to be suitable for publication in Molecular Imprinting, why your paper will 
inspire the other members of your field, and how will it drive research forward. The cover letter must 
discuss the novelty of the work and its importance to the field journal is dedicated to. 
The letter should contain all important details such as: 
 your full name (submitted by), 
 full title of article and short title, 
 full list of authors with affiliations, 
 e-mail of the corresponding author, 
 contact address, telephone/fax numbers of the corresponding author, 
 number of attached files, if there is more than one, 
 status: new, reviewed or accepted (with reference ID if reviewed or accepted). 
The cover letter should explicitly state that the manuscript (or one with substantially the same content, 
by any of the authors) has not been previously published in any language anywhere and that it is not 
under simultaneous consideration or in press by another journal. If related work has been submitted, 
then we may require a preprint to be made available. Reviewers will be asked to comment on the 
overlap between the related submissions. 
Manuscripts that have been previously rejected, or withdrawn after being returned for modification, 
may be resubmitted if the major criticisms have been addressed. The cover letter must state that the 
manuscript is a resubmission, and the former manuscript number should be provided. 
To ensure fair and objective decision-making, authors must declare any associations that pose a 
conflict of interest in connection with evaluated manuscripts (see Editorial Policy for details). Authors 
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may suggest up to two referees not to use, and in such cases additional justification should be 
provided in the cover letter. Authors are encouraged to recommend up to five reviewers who are not 
members of their institution(s) and have never been associated with them or their laboratory(ies); 
please provide contact information for suggested reviewers. The Editors reserve the right to select 
expert reviewers at their discretion. 
SUBMISSION OF REVISED ARTICLES 
Resubmitted manuscripts should be accompanied by a letter outlining a point-by-point response to 
Journal Editor's and reviewers' comments and detailing the changes made to the manuscript. A copy 
of the original manuscript should be included for comparison if the Journal Editor requests one. If it is 
the first revision, authors need to return the revised manuscript within 28 days; if it is the second 
revision, authors need to return the revised manuscript within 14 days. Additional time for 
resubmission must be requested in advance. If the above mentioned deadlines are not met, the 
manuscript will be treated as a new submission. 
For resubmitted manuscripts, please provide us with an editable text and publication-quality figures: 
Tables also need to be included within an editable article file or be submitted separately as editable 
files. 
Supply any figures as separate high-resolution, print-ready digital versions. 
In addition to the editorial remarks, authors are asked to take care that they have prepared the revised 
version according to the Journal's style. Please adopt numbered citation (citation-sequence) style 
referencing. 
PREPARATION OF MANUSCRIPTS  
It is essential that contributors prepare their manuscripts according to the instructions and 
specifications presented below. 
General rules for writing 
The work must demonstrate its novelty, importance to the field of molecular imprinting and its interest 
to chemists in general. Conclusions must be justified by the study; please make your argumentation 
complete and be self-critical as you review your drafts. 
Molecular Imprinting encourages the submission of both substantial full-length bodies of work and 
shorter manuscripts that report novel findings that might be based on a more limited range of 
experiments. There are no specific length restrictions for the overall manuscript or individual sections; 
however, we urge the authors to present and discuss their findings in a concise and accessible 
manner. 
Use simple, declarative sentences and commonly understood terms; avoid long sentences and idle 
words. Please use active voice while writing your manuscript; e.g. ‘we measured snout-vent length’ 
rather than ‘snout-vent length was measured.  We recommend that for clarity you use the past tense 
to narrate particular events in the past, including the procedures, observations, and data of the study 
that you are reporting. Use the present tense for your own general conclusions, the conclusions of 
previous researchers, and generally accepted facts. Thus, most of the Abstract, Methods, and Results 
should be in the past tense, and most of the Introduction and some of the Discussion should be in the 
present tense. Editors may make suggestions for how to improve clarity and readability, as well as to 
strengthen the argument. 
Organization of the Manuscript 
Articles should be organized into the following sections: 
 Title page with: Title (and running title); Author's name(s); Affiliation(s); Address(es), 
 Abstract, 
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 Keywords, 
 Introduction, 
 Methods, 
 Results, 
 Discussion, 
 Acknowledgments (if applicable, these can be included in the cover letter to facilitate double-blind 
review if necessary), 
 References, 
 Figure Legends and Table Captions, 
 Tables, 
 Figures, 
 Supplemental data (if applicable). 
Each of these elements is detailed below. We draw particular attention to the importance of carefully 
preparing the title, keywords and abstract, as these elements are indicators of the manuscript content 
in bibliographic databases and search engines. 
Title 
We suggest the title should be informative, specific to the project, yet concise (75 characters or fewer). 
Please bear in mind that a title that is comprehensible to a broad scientific audience and readers 
outside your field will attract a wider readership. Avoid specialist abbreviations and non-standard 
acronyms. Titles should not be presented in title case (words should not be capitalized). Please also 
provide a brief "running title" of not more than 50 characters. 
Authors, Affiliations, Addresses 
In the cover letter, provide the first names (or initials - if used), middle names (or initials - if used), and 
surnames for all authors. Affiliations should include: 
 Department, 
 University or organization, 
 City, 
 Postal code, 
 State/province (if applicable), 
 Country. 
One of the authors should be designated as the corresponding author to whom inquiries regarding the 
paper should be directed. It is the corresponding author's responsibility to ensure that the author list 
and the summary of the author contributions to the study are accurate and complete. Place an asterisk 
after the name of the corresponding author and provide us with a valid e-mail address. Please note 
that a change in authorship (order of listing, addition or deletion of a name, or corresponding author 
designation) after submission of the manuscript will be implemented only after receipt of signed 
statements of agreement from all parties involved. Footnotes can be used to present additional 
information (for example: permanent, adequate, present postal addresses). If the article has been 
submitted on behalf of a consortium, all consortium members and affiliations should be listed after the 
Acknowledgments. 
Abstract and Image accompanying abstract 
The abstract should not exceed 200 words. The abstract should give a summary of the content of the 
paper and is usually conceptually divided into: Background, Methodology, Principal Findings/Results, 
and Conclusions/Significance. Mention the techniques used without going into methodological detail 
and summarize briefly the most important items of the paper. Please do not include any citations or 
references to tables or figures, and avoid specialist abbreviations and symbols. Because the abstract 
will be published separately by abstracting services, it must be complete and understandable without 
reference to the text. 
Authors may provide a striking image to accompany their article, if one is available. If the image 
(photo, graph, scheme) is judged by the editors to be suitable for publication, it may be featured on the 
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web to highlight the paper online. It is preferable, but not essential, that these should be related strictly 
to the subject reported in the manuscript. The image could originate from the experimental findings 
reported in the manuscript but does not have to constitute a part of the original work and need not be 
reprinted in the article. Images must be original and should be submitted as separate files. 
Keywords 
List keywords for the work presented (maximum of 10), separated by commas. We suggest that 
keywords do not replicate those used in the title. 
Introduction 
The introduction should put the focus of the manuscript into a broader context and should supply 
sufficient background information to allow the reader to understand and evaluate the results without 
referring to previous publications on the topic. As you compose the introduction, think of readers who 
are not experts in this field. Include a brief review of the key literature - use only those references 
required to provide the most salient background rather than an exhaustive review of the topic. 
Relevant controversies or disagreements in the field should be mentioned so that a non-expert reader 
can delve into these issues further. The introduction should conclude with a brief statement of the 
rationale for the study, the hypothesis that was addressed or the overall purpose of the experiments 
reported, and should provide a comment about whether that aim was achieved. 
Methods 
This section should include sufficient technical information to enable the experiments to be 
reproduced. Protocols for new methods or significant modifications to existing methods should be 
included, while previously published or well-established protocols should only be referenced. Describe 
new methods completely and give sources of unusual chemicals, equipment, strains etc. Studies 
presented should comply with our recommendations for distribution of materials and data (see below). 
In theoretical papers comprising the computational analyses, technical details (methods, models 
applied or newly developed) should be provided to enable the readers to reproduce the calculations. 
Results 
This section should provide statistical analyses of all of the experiments that are required to support 
the conclusions of the paper. Reserve extensive interpretation of the results for the Discussion section. 
Details of experiments that are peripheral to the main thrust of the article and that detract from the 
focus of the article should not be included. Present the results as concisely as possible in text, 
table(s), or figure(s) (see below). Avoid extensive use of graphs to present data that might be more 
concisely presented in the text or tables. Graphs illustrating methods commonly used need not be 
shown except in unusual circumstances. Limit photographs to those that are absolutely necessary to 
show the experimental findings. Number figures and tables in the order in which they are cited in the 
text, and be sure to cite all figures and tables. Styles and fonts should match those in the main body of 
the article. Large datasets, including raw data, should be submitted as supporting files. The section 
may be divided into subsections, each with a concise subheading. 
Discussion 
The Discussion should provide an interpretation of the results in relation to previously published work 
and to the experimental system used. It should not contain extensive repetition of the Results or 
reiteration of the Introduction. This section should spell out the major conclusions of the work along 
with some explanation or speculation on the significance of these conclusions. The discussion should 
be concise and tightly argued. 
Acknowledgments 
This section should describe sources of funding that have supported the work. Please also describe 
the role of the study sponsor(s), if any, in study design; collection, analysis, and interpretation of data; 
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writing of the paper; and decision to submit it for publication. Recognition of personal assistance 
should be given as a separate paragraph: people who contributed to the work, but do not fit the criteria 
for authors should be listed along with their contributions. You must ensure that anyone named in the 
acknowledgments agrees to being so named. 
References 
Because all references will be linked electronically to the papers they cite, proper formatting of the 
references is crucial. A complete reference should give the reader enough information to find the 
relevant article. Please pay particular attention to spelling, capitalization and punctuation. 
References to unpublished or submitted work, unpublished conference presentations, personal 
communications, patent applications and patents pending, computer software, databases, and 
websites should be referred to as such only in the body of the text. These should be kept to a 
minimum. The examples are as follows: 
 (J. Smith, unpublished data), 
 (J. Smith and P. Brown, submitted for publication), 
 (J. Smith, personal communication), 
 (J. Smith and P. Brown, presented at the 4th Symposium on Food Microbiology, Overton, 
 IL, 13 - 15 June 1989), 
 (J. C. Odell, April 1970, Process for batch culturing, U.S. patent 484,363,770), 
 (J. Smith, 20 June 1999, Australian Patent Office), 
 … from the GenBank database (http://www.ncbi.nlm.nih.gov/Genbank/index.html), 
 ... using ABC software (version 2.2; Department of Microbiology, State University, 
http://www.stu.micro), 
Published or accepted ('in press') manuscripts, books and book chapters, and theses should be 
included in the reference list. References to published meeting abstracts should be kept to a minimum. 
For all references, list the first 10 authors; add "et al." if there are additional authors. Standard 
abbreviations of journal names according to Thomson Scientific should be used (http://ip-
science.thomsonreuters.com/cgi-bin/jrnlst/jloptions.cgi?PC=master).  
Please use the following style for the reference list: 
Published Papers 
 Kulig P., Zabel B.A., Dubin G., Allen S.J., Ohyama T., Potempa J., et al., Staphylococcus 
aureus-derived staphopain B, a potent cysteine protease activator of plasma chemerin, J. 
Immunol., 2007, 178, 3713-3720. 
 Kulig P., Zabel B.A., Dubin G., Allen S.J., Ohyama T., Potempa J., et al., Stafopaina B 
Staphylococcus aureus, aktywator chemeryny osoczowej, J. Immunol., 2007, 178, 3713-3720, 
(in Polish). 
 Accepted Papers 
 Kulig P., Zabel B.A., Dubin G., Allen S.J., Ohyama T., Potempa J., et al., Staphylococcus 
aureus-derived staphopain B, a potent cysteine protease activator of plasma chemerin, J. 
Immunol., (in press), DOI: 12.3412/01. 
 Kulig P., Zabel B.A., Dubin G., Allen S.J., Ohyama T., Potempa J., et al., Stafopaina B 
Staphylococcus aureus, aktywator chemeryny osoczowej, J. Immunol., (in press, in Polish), 
DOI: 12.3412/01. 
Electronic Journal Articles 
 Dionne M.S., Schneider D.S., Screening the immune system, Genome Biol., 2002,  
http://genomebiology.com/2002/3/4/reviews/1010. 
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Books and book chapters 
 Sambrook J., Russell D.W., Molecular cloning - a laboratory manual, 3rd ed., Cold Spring 
Harbor Laboratory Press, Cold Spring Harbor, 2001. 
 Sambrook J., Cloning and sequencing, In: Sambrook J., Russell D.W. (Eds.), Molecular 
cloning - a laboratory manual, 3rd ed., Cold Spring Harbor Laboratory Press, Cold Spring 
Harbor, 2001 
Theses 
 Agutter A.J., Analysis of sigma factors in S. aureus, PhD thesis, Edinburgh University, 
Edinburgh, UK, 1995. 
 Agutter A.J., Analiza czynnikow sigma S. aureus, PhD thesis, Jagiellonian University, Krakow, 
Poland, 1995, (in Polish). 
Conference proceedings 
 Smith J., Brown P., Reference style guide, In: M. Scott (Ed.), Proceedings of Biochemical 
Society Conference (11-13 July 2007, Warszawa, Poland), Versita Warsaw, 2007, 1335-1791. 
Newspaper articles 
 Sherwin A., The post-genomic era, The Times, 13 July 2007, 1-2. 
 M. Dzierzanowski, Horyzonty, Wprost, 8 July 2007, 18 (in Polish). 
References should be listed and numbered in the order that they appear in the text. In the text, 
citations should be indicated by the reference number in brackets [1]. Multiple citations within a single 
set of brackets should be separated by commas [1,2]. Where there are more than three sequential 
citations, they should be given as a range [1-4]. References in figure captions and tables should be 
listed after references in the text. 
Figures and Figure Legends 
Authors may use photographs, schemes, diagrams, line graphs and bar charts to illustrate their 
findings. Figures included with online submissions should be suitable for onscreen viewing and 
desktop printing. High resolution images should be provided on request or on manuscript acceptance. 
The figures and their lettering should be clear and easy to read, e.g., no labels should be too large or 
too small. Photomicrographs should include a scaled bar and indicate the size. We remind authors 
that it is not acceptable scientific conduct to modify any separate element within an image 
(adjustments of the entire image in brightness, contrast and color balance are justified only if they do 
not misrepresent the original, observed data). Composite figures composed of grouped images such 
as insets from different fields or separate parts of gels must be explained in the figure legend and 
differentiated by use of dividing lines or other means to make composites unambiguous. Figures 
should be numbered consecutively using Arabic numerals and referred to in the text by number. 
Figure legends should follow the main text, each on a separate page. Each figure legend should have 
a concise title and should provide enough information so that the figure is understandable without 
frequent reference to the text. It should inform the reader of key aspects of the figure, but the figure 
should also be discussed in the text. The legend should be succinct, while still explaining all symbols 
and abbreviations. Avoid lengthy descriptions of methods. 
Tables and Table Captions 
Tables must include enough information to warrant table format and should be used only where 
information cannot be presented in the text. Tables should be typed as text, using either 'tabs' or a 
table editor for layout; please do not use graphics software to create tables. Tables occupying more 
than one printed page should be avoided, if possible; larger tables can be published as an appendix. 
Do not use picture elements, text boxes, tabs, or returns in tables. Tables that contain artwork, 
chemical structures, or shading must be submitted as illustrations. Tables should be numbered 
consecutively using Arabic numerals and referred to in the text by number. Table legends should 
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follow the main text, each on a separate page. Each table should have an explanatory caption which 
should be as concise as possible. The headings should be sufficiently clear so that the meaning of the 
data is understandable without reference to the text. Footnotes can be used to explain abbreviations 
but should not include detailed descriptions of the experiment. Citations should be indicated using the 
same style as outlined above. 
Equations 
In-line equations should be typed as text. The use of graphics programs and 'equation editors' should 
be avoided. 
Abbreviations 
Please keep abbreviations to a minimum. In addition to abbreviations for Systeme International 
d'Unités (SI) units of measurement, other common units (e.g., bp, kb, and Da), and chemical symbols 
for the elements, the following should be used without definition: DNA; cDNA; RNA; cRNA; RNase; 
DNase; rRNA; mRNA; tRNA; AMP, ADP, ATP, dAMP, ddATP, GTP, etc.; ATPase, dGTPase, etc.; 
NAD; NAD+; NADH; NADP; NADPH; NADP+; poly(A), poly(dT), etc.; oligo(dT), etc.; UV; PFU; CFU; 
MIC; Tris; DEAE; EDTA; EGTA; HEPES; PCR; and AIDS. Abbreviations for cell lines (e.g., HeLa) as 
well as viruses (e.g., HIV-1, JC virus, BK virus) also need not be defined. Non-standard abbreviations 
should not be used unless they appear at least three times in the text. List all non-standard 
abbreviations, acronyms and symbols in alphabetical order, along with their expanded form, at the end 
of the text. Define them as well upon first use in the text. 
Supplemental Material 
We encourage authors to submit essential supplementary files that additionally support the authors' 
conclusions along with their manuscripts (the principal conclusions should be fully supported without 
referral to the supplemental material). Supplemental material will always remain associated with its 
article and is not subject to any modifications after publication. The decision to publish the material 
with the article if it is accepted will be made by the Editor. Supporting files of no more than 10 MB in 
may be submitted in a variety of formats, but should be publication-ready, as these files will be 
published exactly as supplied. Material must be restricted to large or complex data sets or results that 
cannot be readily displayed because of space or technical limitations. Material that has been 
published previously is not acceptable for posting as supplemental material. 
Supporting files should fall into one of the following categories: 
 Dataset, 
 Additional Figure or Table, 
 Text, 
 Protocol, 
 Multimedia - Audio/Video/Animations (AVI, MPEG, WAV, Quicktime, animated GIF or Flash). 
 If the software required for users to view/use the supplemental material is not embedded in the file, 
you are urged to use shareware or generally available/easily accessible programs. To prevent any 
misunderstandings, we request that authors submit a text file (instruction.txt) containing a brief 
instruction on how to use the files supplied. All supporting information should be referred to in the 
manuscript, with titles (and, if desired, legends) for all files listed under the heading 'Supporting 
Information'. 
NOMENCLATURE 
We strongly recommend the use of correct and established nomenclature wherever possible. Always 
report numerical data (length, weight, and volume) in the appropriate SI units. Please refer to 
International Union of Pure and Applied Chemistry (IUPAC) recommendations available for standard 
metric units. For these units and for molarity, use the prefixes (p= 10-12, n = 10-9, μ= 10-6, m = 10-3, 
c = 10-2, d = 10-1, h = 102, k = 103, M = 106, G = 109, etc.). Use μg/ml or μg/g in place of the 
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ambiguous ppm. When fractions are used to express units, it is preferable to use whole units, such as 
'g' or 'min', in the denominator instead of fractional or multiple units, such as μg or 10 min (for example 
'pmol/min' is preferable to 'nmol/10 min', and 'μmol/g' is preferable to 'nmol/μg'). It is also preferable 
that an unambiguous form such as exponential notation be used; for example, 'μmol g-1 min-1' is 
preferable to 'μmol/g/min'. Units of temperature are presented in degrees centigrade (i.e. 37°C). 
The recognized authority for the names of chemical compounds is Chemical Abstracts. For guidelines 
to the use of biochemical terminology, consult Biochemical Nomenclature and Related Documents. Do 
not express molecular weight in Daltons: molecular weight is a unitless ratio; molecular mass is 
expressed in daltons. For enzymes, use the recommended name assigned by the Nomenclature 
Committee of the International Union of Biochemistry. Use the EC number when one has been 
assigned. 
FORMATTING AND TYPESETTING 
All pages must be numbered consecutively. The whole text (including legends, footnotes, and 
references) should be formatted double-spaced with no hyphenation and automatic word-wrap (no 
hard returns within paragraphs). Please type your text consistently, e.g. take care to distinguish 
between '1' (one), 'I' (capital I) and 'l' (lower-case L) and '0' (zero) and 'O' (capital O), etc. Manuscript 
pages should have line numbers. The font size should be no smaller than 12 points. 
Footnotes and endnotes should be avoided. Allowable footnotes/endnotes may include: the 
designation of the corresponding author of the paper, the current address of an author (if different from 
that shown in the affiliation), abbreviations and acronyms. 
Do not create symbols as graphics or use special fonts that are external to your word processing 
program; use the "insert symbol" function. Indicate paragraph lead-ins in bold type and italicize any 
words that should appear in italics. All Latin names should be italicized, including species names and 
common structures such as: et al.; in vivo; in vitro; ex vivo; in silico; etc.; de novo; a priori; ab initio; 
vice versa; in situ; ad hoc; sensu stricto; i.e.; ca. /circa; n.b. /nota bene. Decimal multiples or 
submultiples of units are indicated by the use of prefixes. There should be a single space between 
most units and the corresponding number; the only exceptions are: 1%, 1‰, 1°C, 1°, 1', 1". 
DISTRIBUTION OF MATERIALS AND DATA 
The publication of an article in Molecular imprinting is subject to the understanding that authors will 
make all data and associated protocols available to readers on request. The Methods section should 
include details of how materials and information may be obtained. In cases of dispute, authors may be 
required to make any primary data available to the Journal Editor. 
COPYRIGHT 
All authors retain copyright, unless – due to their local circumstances – their work is not copyrighted. 
The non-commercial use of each article will be governed by the Creative Commons Attribution-
NonCommercial-NoDerivs license. The corresponding author grants Versita the exclusive license to 
commercial use of the article, by signing the License to Publish. Scanned copy of license should be 
submitted via Editorial Manager along with the manuscript and covering letter. In case of any problems 
please contact Editorial Office by e-mail molim.editorial@degruyteropen.com.  
OUTLINE OF THE PRODUCTION PROCESS 
Once an article has been accepted for publication, the manuscript files are transferred into our 
production system to be language-edited and formatted. Language and technical editors reserve the 
privilege of editing manuscripts to conform with the stylistic conventions of the journal. Once the article 
has been typeset, PDF proofs are generated so that authors can approve all editing and layout. 
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Electronic Proofs 
Proofreading should be carried out once a final draft has been produced. Since the proofreading stage 
is the last opportunity to correct the article to be published, the authors are requested to make every 
effort to check for errors in their proofs before the paper is posted online. Please note that only 
essential changes can be made at this stage and extensive corrections, additions, or deletions will not 
be allowed. Limit changes to correction of spelling errors, incorrect data, grammatical errors, and 
updated information for references to articles that have been submitted or are in press. If URLs have 
been provided in the article, recheck the sites to ensure that the addresses are still accurate and the 
material that you expect the reader to find is indeed there. Important new information that has become 
available between acceptance of the manuscript and receipt of the proofs may be inserted into the 
proof with the permission of the editor. 
Additionally, authors may be asked to address remarks and queries from the language and/or 
technical editors. Queries are written only to request necessary information or clarification of an 
unclear passage or to draw attention to edits that may have altered the sense. Please note that 
language/technical editors do not query at every instance where a change has been made. It is the 
author's responsibility to read the entire text, tables, and figure legends, not just items queried. Major 
alterations made will always be submitted to the authors for approval. 
Manuscripts submitted under multiple authorship are published on the assumption that the final 
version of the manuscript has been seen and approved by all authors. The Corresponding author will 
receive e-mail notification when a downloadable PDF file is available and should return comments on 
the proofs within a maximum of 3 days of receipt. Comments should be e-mailed to Editorial Office 
Please note that they should not be faxed, nor mailed or sent by a courier service. 
